28 June 2022

• What to Know About Monoclonal Antibodies as COVID-19 Treatments - TIME
• Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19 | NEJM - nejm.org
• Effectiveness of monoclonal antibodies and directly acting antivirals against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages - News-Medical.Net
• The Future of Monoclonal Antibodies Market Economy Size Expected a Growth of USD 155.2 Billion by 2028; According to Vantage Market Research - GlobeNewswire
• The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination - Science